131
Breast cancer tissue array for antibody screening , including TNM, clinical stage, pathology grade, and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores
(No reviews yet)
Write a Review
- SKU:
- 131-BR1009-GEN
- Availability:
- IN STOCK
Description
Breast cancer tissue array for antibody screening , including TNM, clinical stage, pathology grade, and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores
Related Products
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131
NULL399.00
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131-BR1503d-GEN
Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 95 cases/190 cores
131
NULL642.00
Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 95 cases/190 cores
131-BR1901-GEN
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1504c
131
NULL399.00
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced...
131-BR1504b-GEN
Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 44 cases/88 cores
131
NULL399.00
Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 44 cases/88 cores
131-BR881-GEN
Breast cancer tissue array (most of triple negative), including TNM, clinical stage and pathology grade,IHC markers (ER, PR, Her-2) results, 60 cases/120 cores
131
NULL439.00
Breast cancer tissue array (most of triple negative), including TNM, clinical stage and pathology grade,IHC markers (ER, PR, Her-2) results, 60 cases/120 cores
131-BR1202-GEN
Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, with ER, PR and Her-2 IHC results, 50 cases/100 cores, replacing BR10010d
131
NULL439.00
Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, with ER, PR and Her-2 IHC results, 50 cases/100 cores, replacing BR10010d
131-BR10010e-GEN
Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (Her-2/PR/ER), 4 cases/8 cores, replacing BR082b
131
NULL206.00
Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (Her-2/PR/ER), 4 cases/8 cores, replacing BR082b
131-BR082c-GEN
Breast tumor tissue array (11 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores
131
NULL541.00
Breast tumor tissue array (11 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores
131-BR20817-GEN
Breast tumor tissue array (13 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores
131
NULL541.00
Breast tumor tissue array (13 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores
131-BR20819-GEN